Basel Medical Group Ltd (BMGL) is a Medical/Nursing Services company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for BMGL, including 1 insider trade, 1 SEC filing and 1 press release or news item. The most recent was published Oct 30, 2026.
Price$0.48-4.53 (-90.49%)
2026-08-132026-11-13
Financial highlights
Full financials- Revenue, FY2026
- SGD 16.44M
- Revenue growth
- +45.2%
- Net income, FY2026
- -SGD 748.0K
- Net margin
- -4.5%
- Free cash flow, FY2026
- -SGD 883.4K
- Cash
- SGD 529.9K
For fiscal 2026 (ended Jun 30, 2026), from SEC filings. Not investment advice.
News · 26 weeks21-62%
2026-05-172026-11-08
Mix1390d
- SEC Filings7(54%)
- Insider2(15%)
- Offering2(15%)
- Other2(15%)
Activity · 52 weeks3727 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 20-F filed by Basel Medical Group Ltd20-F - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- INSIDERSEC Form 3 filed by Basel Medical Group Ltd3 - Basel Medical Group Ltd (0002004489) (Issuer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRBasel Medical Group Ltd (BMGL) Closes Registered Direct OfferingSingapore, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today closed its registered direct offering of 6,000,000 units, raising gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million. The Company intends to use all of the net proceeds from this offering for general working capital purposes, mergers and acquisitions and other general corporate purposes. As previously announced, the Company entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent (the "Placement Agent"), as well as a securities purchase agreement with certain purchasers, each dated October 7, 2026, pursua
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 424B4 filed by Basel Medical Group Ltd424B4 - Basel Medical Group Ltd (0002004489) (Filer)
- PRBasel Medical Group Ltd (BMGL) Prices Registered Direct OfferingSingapore, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent (the "Placement Agent"), as well as a securities purchase agreement with certain purchasers, pursuant to which the Company will issue and sell 6,000,000 units (the "Units"), at a public offering price of US$1.33 per Unit, each consisting of one ordinary share with no par value (each an "Ordinary Share" and collectively the "Ordinary Shares") or one Pre-Funded Warrant (defined below) of the Company, and one warrant ("Common Warrant"), each to purchase one Ordinary Share. The Ordinary Shares ar
- INSIDERSEC Form 3 filed by new insider Hong Frederick Shieh Ming3 - Basel Medical Group Ltd (0002004489) (Issuer)
- SECSEC Form EFFECT filed by Basel Medical Group LtdEFFECT - Basel Medical Group Ltd (0002004489) (Filer)
- SECAmendment: SEC Form F-1/A filed by Basel Medical Group LtdF-1/A - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form F-1 filed by Basel Medical Group LtdF-1 - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- INSIDERSEC Form 3 filed by new insider Neo Alton Chun How3 - Basel Medical Group Ltd (0002004489) (Issuer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRBMGL Regains Compliance With Nasdaq Minimum Bid Price RequirementSingapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq minimum bid price rule. On January 22, 2026, Nasdaq notified the Company that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. Since then, Nasdaq has determined that for the last 10 consecutive business days, from June 23, 2026 to July 7, 2026, the closing bid price of the Company’s ordinary shares has been at $1.00 per share or greater. Accordingly,
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRBMGL to Effect Reverse Share Split on June 22, 2026SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), a medical clinic operator in Singapore, today announced that the Company's board of directors has approved the consolidation of the Company's issued and outstanding shares of the Company on a 1-for-12 ratio with the marketplace effective date of June 22, 2026. The objective of the reverse share split is to enable the Company to recomply with Nasdaq Marketplace Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1 per share. According to the law of the British Virgin Islands, the jurisdiction of the Company's incorporation, and its memorandum and articles of
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- INSIDERSEC Form 3 filed by new insider Soong Kwek Yoon3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lu Jianing Jn3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chen Tony3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chhoa Darren Yen Feng3 - Basel Medical Group Ltd (0002004489) (Issuer)
BMGL FAQ
9 questionsWhat is the latest news on BMGL?
In the last 30 days Quantisnow tracked 3 wire items for BMGL: 1 insider trade, 1 SEC filing and 1 press release or news item. The most recent was published on October 30, 2026.What is BMGL revenue?
Basel Medical Group Ltd (BMGL) reported SGD 16.44M of revenue for fiscal 2026 (ended Jun 30, 2026). That is up 45.2% from the year before.Is BMGL profitable?
No. Basel Medical Group Ltd reported a net loss of SGD 748.0K for fiscal 2026 (ended Jun 30, 2026).How much cash and debt does BMGL have?
Basel Medical Group Ltd reported SGD 529.9K in cash and cash equivalents and SGD 12.05M of debt on its most recent balance sheet in SEC filings.Where does BMGL stock trade?
Basel Medical Group Ltd (BMGL) is listed on NASDAQ.What sector and industry is BMGL in?
Basel Medical Group Ltd operates in the Health Care sector, Medical/Nursing Services industry.When did Basel Medical Group Ltd go public?
Basel Medical Group Ltd (BMGL) completed its IPO in 2025.What companies are similar to BMGL?
Notable peers in the same industry include AVAH (Aveanna Healthcare Holdings Inc.), LFST (LifeStance Health Group Inc.), HIMS (Hims & Hers Health Inc.), OPCH (Option Care Health Inc.), CHE (Chemed Corp). Compare BMGL side-by-side with any of them on Quantisnow.How can I track BMGL on Quantisnow?
Quantisnow aggregates Basel Medical Group Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BMGL to receive live email and push alerts on every new disclosure.